Addendum to the note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections to specifically address the clinical development of new agents to treat disease due to Mycobacterium Tuberculosis - Scientific guideline

This document is an addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. It covers the evaluation of agents for the treatment of disease due to Mycobacterium tuberculosis.

Keywords: Mycobacterium tuberculosis, pulmonary and extrapulmonary tuberculosis, combination regimens, multidrug resistant M. tuberculosis, early bactericidal activity (EBA), sputum culture conversion (SCC)

Document history

Topics

How useful was this page?

Add your rating
Average
1 rating
1 rating
2 ratings